KalVista Pharmaceuticals, Inc. (KALV)
14.91
-0.21
(-1.39%)
USD |
NASDAQ |
Feb 13, 16:00
14.90
-0.01
(-0.07%)
After-Hours: 20:00
KalVista Pharmaceuticals EPS Diluted (Quarterly) : -0.9183 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 0.0587 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Plus Therapeutics, Inc. | -0.0412 |
| BioStem Technologies, Inc. | 0.0328 |
| Protokinetix, Inc. | -0.0002 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -49.48M |
| Revenue (Quarterly) | 13.69M |
| Total Expenses (Quarterly) | 63.17M |
| Enterprise Value | 727.07M |
| Gross Profit Margin (Quarterly) | 91.00% |
| Profit Margin (Quarterly) | -361.4% |
| Earnings Yield | -26.91% |
| Normalized Earnings Yield | -26.76 |